Rapid injection of rocuronium reduces withdrawal movement on injection.
OBJECTIVE
To test whether rapid injection of rocuronium reduces withdrawal movement on injection.


METHODS
Randomized, prospective trial.


METHODS
Operating room in a university hospital.


METHODS
150 ASA physical status I and II patients aged 18 to 60 years, undergoing general anesthesia.


METHODS
Patients were randomized to three groups. After undergoing anesthesia induction with thiopental sodium, then 5 seconds later receiving a rubber tourniquet applied to the mid-forearm to stop intravenous (IV) flow by gravity, the pretreatment drug was injected. The tourniquet was held for 15 seconds then released, and 1.0 mg/kg of 1% rocuronium was injected IV. Group C patients (n = 50) were pretreated with 0.1 mL/kg of 0.9% NaCl and then injected with rocuronium slowly within 10 seconds. Group L patients (n = 50) were pretreated with 0.1 mL/kg of preservative-free 1% lidocaine and then injected with rocuronium slowly within 10 seconds. Group R patients (n = 50) were pretreated with 0.1 mL/kg of 0.9% NaCl and then rapidly injected with rocuronium within approximately one second (as quickly as possible).


METHODS
After injection of the patient with the study drug, a single anesthesiologist with no knowledge of the study protocol graded each patient's response as follows: 0 = no response; 1 = mild movement limited to the wrist only; 2 = moderate movement involving the elbow and shoulder; and 3 = severe movement involving more than one extremity.


RESULTS
Group C had the most intense and frequent withdrawal response. The frequency and intensity of withdrawal movement was significantly less in Groups L and R than Group C. No significant difference in withdrawal response between Groups L and R was noted.


CONCLUSIONS
Withdrawal response can be significantly reduced for rocuronium injection without lidocaine pretreatment, simply through rapid injection.
Lee
Yong Cheol
YC
Department of Anesthesiology and Pain Medicine, Keimyung University, School of Medicine, Joong-gu, Daegu 700-712, Korea. yclee@dsmc.or.kr
Jang
Young Ho
YH
Kim
Jin Mo
JM
Lee
Sang Gyu
SG
D000293:Adolescent; D000328:Adult; D000732:Androstanols / Q000008:administration & dosage* / Q000009:adverse effects; D018686:Anesthetics, Intravenous / Q000627:therapeutic use; D000779:Anesthetics, Local / Q000627:therapeutic use; D005260:Female; D006785:Hospitals, University; D006801:Humans; D007275:Injections, Intravenous; D008012:Lidocaine / Q000627:therapeutic use*; D008297:Male; D008875:Middle Aged; D009068:Movement / Q000187:drug effects; D003473:Neuromuscular Nondepolarizing Agents / Q000008:administration & dosage* / Q000009:adverse effects; D010146:Pain / Q000139:chemically induced / Q000517:prevention & control*; D011446:Prospective Studies; D000077123:Rocuronium; D012965:Sodium Chloride / Q000008:administration & dosage; D013874:Thiopental / Q000627:therapeutic use; D014111:Tourniquets; D055815:Young Adult
D000732:Androstanols; D018686:Anesthetics, Intravenous; D000779:Anesthetics, Local; D003473:Neuromuscular Nondepolarizing Agents; D012965:Sodium Chloride; D008012:Lidocaine; D013874:Thiopental; D000077123:Rocuronium